The aim of the present study was to evaluate the effect of ephrinB2 gene-transfected canine periodontal ligament stem cells (cPdLScs) on the regulation of osteogenic differentiation. cPdLScs were transfected with a transgenic null-control green fluorescent protein (GFP) vector (termed Vector-cPDLSCs) or with NFNB2 GFP-Blasticidin (termed EfnB2-cPdLScs). Subsequently, the osteogenic differentiation of Vector-cPdLScs and EfnB2-cPdLScs was assessed by reverse transcription-quantitative polymerase chain reaction (RT-qPcR), alkaline phosphatase (ALP) assay and Alizarin Red S staining. The migratory abilities of cPdLScs, Vector-cPdLScs and EfnB2-cPdLScs were also assessed. Following osteogenic induction of Vector-cPdLScs and EfnB2-cPdLScs, the protein expression levels of collagen I, Runt-related transcription factor 2, osteocalcin, ephrin type-B receptor 4 (EphB4), phospho-EphB4, ephrinB2 and phospho-ephrinB2 were analyzed by western blot assays. Following gene transfection, the RT-qPcR and western blotting results revealed that the mRNA and protein expression levels of ephrinB2, respectively, were significantly increased in EfnB2-cPdLScs compared with that in Vector-cPdLScs (P<0.05). ALP and Alizarin Red S staining assays revealed increased ALP activity and mineralization nodules, respectively, in EfnB2-cPdLScs. cell proliferation and migration assays revealed that EfnB2-cPdLScs exhibited enhanced proliferation and migration compared with Vector-cPdLScs (P<0.05). In conclusion, the findings of the current study indicated that ephrinB2 gene-modified cPDLSCs exhibited enhanced osteogenic differentiation, with the ephrinB2 reverse signaling and EphB4 forward signaling pathways serving a key role in this process. Furthermore, ephrinB2 gene modification was observed to promote the migration and proliferation of cPdLScs.